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Plant intracellular nucleotide-binding leucine-rich repeat (NLR)
immune receptors often function in pairs to detect pathogen
effectors and activate defense. The Arabidopsis RRS1-R–RPS4 NLR
pair recognizes the bacterial effectors AvrRps4 and PopP2 via an
integrated WRKY transcription factor domain in RRS1-R that
mimics the effector’s authentic targets. How the complex activates
defense upon effector recognition is unknown. Deletion of the
WRKY domain results in an RRS1 allele that triggers constitutive
RPS4-dependent defense activation, suggesting that in the ab-
sence of effector, the WRKY domain contributes to maintaining
the complex in an inactive state. We show the WRKY domain
interacts with the adjacent domain 4, and that the inactive state
of RRS1 is maintained by WRKY–domain 4 interactions before li-
gand detection. AvrRps4 interaction with the WRKY domain dis-
rupts WRKY–domain 4 association, thus derepressing the complex.
PopP2-triggered activation is less easily explained by such disrup-
tion and involves the longer C-terminal extension of RRS1-R. Fur-
thermore, some mutations in RPS4 and RRS1 compromise PopP2
but not AvrRps4 recognition, suggesting that AvrRps4 and PopP2
derepress the complex differently. Consistent with this, a “revers-
ibly closed” conformation of RRS1-R, engineered in a method
exploiting the high affinity of colicin E9 and Im9 domains, revers-
ibly loses AvrRps4, but not PopP2 responsiveness. Following RRS1
derepression, interactions between domain 4 and the RPS4 C-
terminal domain likely contribute to activation. Simultaneous
relief of autoinhibition and activation may contribute to defense
activation in many immune receptors.
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Plants and animals carry both intracellular and cell-surfacelocalized immune receptors that activate defense upon rec-
ognition of molecules from pathogens. Plant transmembrane
receptors recognize extracellular microbial molecules and acti-
vate pattern-triggered immunity. Pathogen effector proteins
suppress immunity and promote pathogen virulence, but plant in-
tracellular immune receptors can recognize intracellular effectors,
either directly or indirectly (1, 2). Genetic variation for disease
resistance usually maps to genes that encode intracellular receptors
that are modular nucleotide-binding (NB) leucine-rich repeat
(LRR) proteins, termed NLRs, that resemble animal NOD-like
immune receptors (3, 4). Plant NLRs usually carry either an
N-terminal Toll–interleukin-1 receptor/resistance protein (TIR)
domain or an N-terminal coiled-coil (CC) domain (5). Recognition
of effectors by NLRs leads to effector-triggered immunity, often
culminating in a hypersensitive cell death response (HR).
How plant NLR proteins function remains unclear. The NB
domain may act as molecular switch driven by ATP or ADP
binding, which, upon effector recognition, may change confor-
mation to stabilize the ATP-bound form of the NLR, leading to
activation (6–9). TIR domains of many TIR-NLRs such as flax L6
and Arabidopsis RPP1 and RPS4 are sufficient to activate defense
signaling when overexpressed (10–14). Allelic variation for recog-
nition in NLRs usually maps to the LRR domain (15). Effector–
LRR interaction might relieve autoinhibitory intramolecular inter-
actions, enabling activation of the N-terminal signaling domain (16).
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Plants and animals carry intracellular nucleotide-binding leucine-
rich repeat (NLR) immune receptors. How NLR receptors activate
defense on perceiving pathogen molecules is poorly understood,
especially in plants. Some NLRs function in pairs, with one NLR
carrying a domain that mimics a pathogen effector target. Ef-
fector action on this domain activates the second “helper” NLR.
In the Arabidopsis RPS4 and RRS1 pair, RRS1 carries a WRKY
transcription factor domain targeted by bacterial effectors
AvrRps4 and PopP2. We monitored conformational changes in
RPS4–RRS1 during activation and developed a “molecular pad-
lock” to reversibly restrict such changes. This revealed domains
within RRS1 required to keep the RRS1–RPS4 complex inactive
prior to effector detection, and specific domain–domain inter-
actions whose disruption or modification contributes to defense
activation.
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Some NLRs function in pairs (17, 18), each of which special-
izes into sensor or executor (or “helper”) roles for effector
perception and immune signaling. The sensor NLR can detect
effectors via an integrated domain (ID) that mimics an authentic
pathogen target (19, 20). Genetically linked sensor and executor
NLR pairs, such as rice RGA4 and RGA5 and Arabidopsis RRS1
and RPS4, form immune complexes in which the sensor NLR
carrying an ID (RGA5, RRS1) detects effectors, and helper
NLR (RGA4, RPS4) activates defense (3, 21). The sensors
RRS1 and RGA5 negatively regulate their cognate executors
RPS4 and RGA4 (17, 22). Some sensor NLRs require unlinked
“helper NLRs” to activate signaling (18, 23–25). Failure to ap-
propriately interact with partners can result in loss of defense
activation or autoactivity (26–28).
How paired immune receptor complexes convert effector
sensing into defense activation is unknown. RRS1-R encodes a
TIR-NLR (TNL) protein with a WRKY domain near the C
terminus. WRKY transcription factors are key regulators of
plant defense. RRS1-R from accessions Ws-2 forms an immune
receptor complex with RPS4 that recognizes AvrRps4 from
Pseudomonas syringae and PopP2 from Ralstonia solanacearum
(29–31). AvrRps4 and PopP2 target a subset of host WRKY
proteins to suppress host defense and promote pathogen viru-
lence. Both effectors are perceived via the integrated WRKY
domain of RRS1-R. AvrRps4 interacts with, and PopP2 acety-
lates, the WRKY domain, resulting in activation of the RPS4–
RRS1 complex and subsequent defense activation (32, 33).
RRS1 thus monitors for effectors that target WRKY proteins.
Arabidopsis accessions also carry an NLR pair RRS1B/RPS4B
(sharing ∼70% identity with and closely linked to RRS1/RPS4)
that detects AvrRps4, but not PopP2 (26). PopP2 is not recog-
nized by RRS1-S/RPS4 from the Arabidopsis accession Col-0,
likely due to a truncation of the C-terminal extension beyond
the WRKY domain in RRS1-R (33). Since RRS1-S/RPS4 is fully
responsive to AvrRps4, PopP2 might activate the immune com-
plex differently from AvrRps4.
How do immune complex reconfigurations convert effector
sensing into defense activation? We found that the integrated
WRKY domain of RRS1 negatively regulates the immune re-
ceptor complex, and effector interactions with the WRKY do-
main abrogate its negative regulation. RRS1-R engineered with
a “reversibly closed” conformation exhibits reversible loss of
AvrRps4, but not PopP2 recognition. We infer substantial rear-
rangements of the C-terminal domains (CTDs) of RRS1-R are
required during AvrRps4 responsiveness, while more subtle
changes are involved in PopP2 responsiveness. Genetic evidence
suggests the post-LRR CTD of RPS4 is required for subsequent
signaling, with some amino acids required for PopP2 but not
AvrRps4 responsiveness. This combination of relief of auto-
inhibition and activation will likely operate in many other im-
mune receptor systems.
Results
RRS1 WRKY Domain (DOM5) Is Required for Autoinhibition, and
Domain 4 (DOM4) for Activation of the RRS1–RPS4 Complex. We
tested the role of the WRKY domain of RRS1 in regulating the
RRS1–RPS4 complex in the absence of effector. RRS1-R muta-
tions in the WRKY domain constitutively activate defense [e.g.,
sensitive to low humidity 1 (slh1) and K1221Q] or block signaling
(e.g., K1221R) (33, 34). As the loss of DNA binding by RRS1-Sslh1 or
RRS1-RK1221R is insufficient to trigger activation (32, 33), DNA
binding by the WRKY domain, or its loss, is unlikely to directly
activate defense. We hypothesized that, after interaction with an
effector, the WRKY domain initiates conformational changes in
RRS1 domains that are sensed by RPS4, activating defense.
For RRS1, we defined the 322 aa between the LRRs and
WRKY as domain 4 (DOM4 or D4) and the amino acids C-
terminal to the WRKY domain as domain 6 (DOM6-R is 104 aa,
DOM6-S is 21 aa) (SI Appendix, Fig. S1A). RPS4 encodes a
TNL with 338 aa C-terminal to the LRR, designated here the
CTD (SI Appendix, Fig. S1A). These domain boundaries were
defined to minimize potential disruption during domain swaps.
For simplicity, chimera proteins are represented with domains
from RRS1 and RPS4 as A’s, and domains from RRS1B and
RPS4B as B’s.
To investigate the roles of DOM6, WRKY, and DOM4, we
made several C-terminal deletions of RRS1-R and analyzed
function using transient assays in Nicotiana tabacum (tobacco)
leaves. We confirmed that deleting 83 aa of RRS1-R (ΔC83)
abolishes PopP2 but not AvrRps4 recognition when coexpressed
with RPS4, phenocopying RRS1-S (Fig. 1A). Similarly, RRS1-
RΔC101, in which all but 3 aa of DOM6-R are deleted, responds
to AvrRps4 and is not constitutively active (Fig. 1A). Thus,
DOM6-R of RRS1-R is dispensable for AvrRps4 recognition but
is essential for converting PopP2 acetylation of the WRKY do-
main into defense activation.
Notably, further deletion to remove the WRKY domain
(DOM5), making RRS1-RΔD56 (lacking domains 5 and 6), re-
sults in constitutive RPS4-dependent activity (Fig. 1A). Domain
swaps in which the RRS1-R WRKY domain was replaced with a
bacterial LexA DNA binding domain (33), or with the RRS1B
WRKY domain (56.6% amino acid identity), also show RPS4-
dependent autoactivity (Fig. 1B). Unlike the inactive RRS1-Sslh1
(33), RRS1-S(AAAALA) with the WRKY replaced by LexA
(L), also shows RPS4-dependent constitutive activity (Fig. 1B).
Thus, removal or perturbation of the WRKY domain is sufficient
to activate defense, implying that it acts as a negative regulator of
the immune complex, rather than in downstream signaling. In-
triguingly, substituting DOM6 of RRS1 with that of RRS1B
leads to autoactivity of RRS1(AAAAAB), while deletion of
DOM6 in RRS1 does not (Fig. 1 A and B). Therefore, this
constitutive activity is likely caused by the presence of an in-
compatible DOM6-B, rather than by the lack of DOM6-R.
Replacing DOM5 and DOM6 with the equivalent domains from
RRS1B [to make RRS1-R(AAAABB)], or with the WRKY
domain and C-terminal amino acids from WRKY41 [RRS1-R
(AAAAW41)], also results in autoactivity (Fig. 1B and SI Ap-
pendix, Fig. S1B). WRKY41 is closely related to both RRS1 and
RRS1B WRKY domains (SI Appendix, Fig. S1B) and interacts
with AvrRps4 and PopP2 (33), suggesting that WRKY41 may
represent the original effector target from which these integrated
WRKY domains evolved. We hypothesize that the WRKY do-
mains of RRS1B and WRKY41 fail to suppress DOM4 of RRS1
in RRS1-R(AAAABB) and RRS1-R(AAAAW41), thus allowing
RRS1-R to activate RPS4. Reciprocal DOM5 and/or DOM6
swaps in RRS1B all lead to RPS4B-dependent autoactivity (SI
Appendix, Fig. S1C), suggesting that compatible interactions
between WRKY and its adjacent domains are important for
autoinhibition in both the A and B pair complexes. This also
indicates that IDs must coevolve with the main body of the NLR
receptors after fusion.
The autoactivity of RRS1-RΔD56 requires DOM4 of RRS1-
R, since deletion of DOM4 abolishes RRS1-RΔD456 autoac-
tivity and effector responsiveness (Fig. 1A). The importance of
DOM4 for activation is also shown by DOM4 swaps. Both RRS1
(AAABAA) + RPS4 and RRS1B(BBBABB) + RPS4B combi-
nations fail to respond to effectors (Fig. 1C and SI Appendix, Fig.
S2B). Swapping NB-ARC or LRR domains of RRS1 with
RRS1B abrogates effector responsiveness of RRS1(ABAAAA)
and RRS1(AABAAA) without causing autoactivity (Fig. 1C),
suggesting that matching NB-ARC and LRR domains are re-
quired for complex activation. SI Appendix, Fig. S1A illustrates
the domain boundaries for swapping and deletion experiments.
Lack of effector responsiveness is not due to the lack of R pro-
tein expression (SI Appendix, Fig. S1D).
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To test whether the expressed subdomain D56-R (DOM5 +
DOM6-R) associates with other domains of RRS1 to suppress
activation, we carried out coimmunoprecipitation (co-IP) ex-
periments after transient coexpression in Nicotiana benthamiana
(Nb) leaves. D56-R coimmunoprecipitates more strongly with
expressed subdomain 4 (DOM4) than with NB-ARC or LRR of
RRS1, indicating that D56-R association with DOM4 could be
responsible for the negative regulation of the RRS1–RPS4
complex (SI Appendix, Fig. S1E). Nevertheless, in trans coex-
pression of D56-R cannot suppress RRS1-RΔD56 + RPS4-
triggered HR (SI Appendix, Fig. S1F), suggesting that D56-R
must be in the context of full-length RRS1-R for auto-
inhibition. Similarly, in trans coexpression of DOM4 and RRS1-
RΔD456 cannot reconstitute the autoactivity of RRS1-RΔD56 +
RPS4, and RRS1-RΔD456 + D456-R is nonresponsive to AvrRps4
(SI Appendix, Fig. S1F). These data suggest intramolecular inter-
actions between domains of RRS1 are required for autoinhibition
and activation of the immune complex.
Distinct Genetic Requirements in RPS4 and RRS1 for PopP2 and
AvrRps4 Responsiveness, and for Autoactivity. RRS1-RΔD56 re-
quires a signaling-competent RPS4 to trigger cell death. The
RPS4 P-loop mutant RPS4(K242A) or TIR domain mutant
RPS4(SHAA) (13) fail to activate HR when coexpressed with
RRS1-RΔD56 (SI Appendix, Fig. S2A). In contrast, the P-loop
mutant of RRS1-RΔD56(K185A) still activates RPS4-dependent
HR (SI Appendix, Fig. S2A).
Upon derepression, RRS1 signals via RPS4. Either truncation
of RPS4 CTD, or a CTD swap with RPS4B [RPS4(AAAB)], or
several point mutations in the CTD (C887Y, S914F, G952E,
G997E), impair RPS4 + RRS1-RΔD56–triggered HR (Fig. 2A).
These point mutations were found in a genetic screen (34).
Compared with C887Y and S914F, mutations G952E and
G997E of RPS4 show a stronger impairment (Fig. 2A). These
data suggest that the CTD is essential for RPS4 to respond to a
derepressed RRS1-RΔD56, possibly via DOM4.
Using domain swaps, we tested whether the cognate DOM4 and
CTD from RRS1-R/RPS4 (A pair) or RRS1B/RPS4B (B pair) are
required for effector-triggered activation. DOM4 swaps between
RRS1-R and RRS1B result in no response to AvrRps4 and PopP2
when coexpressed with their cognate pair partners (Fig. 2B and SI
Appendix, Fig. S2B). After swapping the CTD, RPS4B(BBBA) +
RRS1B fails to respond to either effector, while RPS4(AAAB) +
RRS1-R recognizes both AvrRps4 and PopP2 (Fig. 2B and SI
Appendix, Fig. S2B). Since RPS4(AAAB) + RRS1-RΔD56 fail to
trigger cell death (Fig. 2A), the presence of D56 in RRS1-R
compared with RRS1-RΔD56 must explain this contrast in func-
tionality (Fig. 2 G and H). RPS4 and RPS4B chimeras express at
levels comparable to wild type (SI Appendix, Fig. S2D). These data
suggest that DOM4 and CTD complementarity is important for
effector responsiveness. However, even when DOM4 and CTD
are from matching pairs [RRS1-R(AAABAA) + RPS4(AAAB);
RRS1B(BBBABB) + RPS4B(BBBA)], the effector responsive-
ness is lost (Fig. 2B and SI Appendix, Fig. S2B), indicating that a
matching DOM4/CTD is not sufficient for function.
We next examined previously identified RRS1 DOM4 and
RPS4 CTD mutants (34) for effector responsiveness in transient
assays. When coexpressed with RPS4, RRS1-R DOM4 mutants
S983F and E1070K both show reduced PopP2 but full AvrRps4
responsiveness (Fig. 2C). When the RPS4 CTD mutant C887Y is
coexpressed with RRS1-R, it also shows partial loss of PopP2,
but not of AvrRps4, responsiveness (Fig. 2D). Quantification
confirms the stronger impairment of PopP2 compared with
AvrRps4 responsiveness for these mutants (Fig. 2F). Other RPS4
CTD mutants tested (S914F, G952E, G997E) lose recognition of
both effectors in combination with RRS1-R, suggesting that these
residues are necessary for activation triggered by either effector
(34) (SI Appendix, Fig. S2C). Some residues in DOM4 and CTD
A
B
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Fig. 1. RRS1 WRKY domain (DOM5) is required for autoinhibition and do-
main 4 (DOM4) for activation of the RRS1–RPS4 complex. (A) Successive
deletions of RRS1-R compromise effector responsiveness or autoinhibition.
Each tobacco leaf section was coinfiltrated to transiently express RPS4 and a
truncated RRS1-R with either mCherry (mCh), AvrRps4:mCh or PopP2:mCh.
ΔC83, deletion of C-terminal 83 aa of RRS1-R; ΔD56, deletion of the WRKY
domain (DOM5) and domain 6 of RRS1-R (DOM6-R). (B) Replacement of
DOM5 and/or DOM6 of RRS1 with that of RRS1B causes RPS4-dependent
autoactivity. Each leaf section was infiltrated to express a chimeric RRS1
with or without RPS4. The chimeras are represented with domains from
RRS1 as A’s, domains from RRS1B as B’s, bacterial LexA shown as L, and the
WRKY domain and C-terminal amino acids of WRKY41 shown as W41. (C)
Loss of effector responsiveness in the RRS1-R chimeras where NB-ARC, LRR,
or domain 4 (DOM4) is replaced by an equivalent domain of RRS1B, when
coexpressed with RPS4. Each section represents the presence (yellow) or
absence (green) of HR in tobacco leaves at 4 d postinfiltration (dpi). HRs
were assessed at 4 dpi. Phenotypes are representative of at least three
consistent replicates.
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are thus more important for PopP2- than for AvrRps4-triggered
activation. We hypothesize that these residues are in a unique
DOM4–CTD interaction interface that participates in PopP2-
triggered activation, likely involving RRS1-R domain 6 (DOM6-R).
Consistent with this idea, this partial PopP2 responsiveness is
further decreased when the two mutants are combined in RRS1-
RS983F+RPS4C887Y, or RRS1-RE1070K+RPS4C887Y (Fig. 2E and F).
Importantly, these combinations can still recognize AvrRps4, al-
beit showing weaker HR (Fig. 2 E and F). We therefore infer that
these residues of DOM4 (S983, E1070) and CTD (C887) may
cooperate to enable PopP2-triggered complex activation via a
mechanism that is not required for AvrRps4 responsiveness.
DOM6-R is specifically required for PopP2 but not AvrRps4
recognition (Fig. 1A). D56-R enables complex activation even in a
noncognate DOM4(A)/CTD(B) combination; RRS1-R + RPS4
(AAAB) confers responsiveness to both effectors, whereas RRS1-
RΔD56 + RPS4(AAAB) fail to trigger HR (Fig. 2 A and B). Ad-
ditionally, RRS1-Rslh1 + RPS4(AAAB) trigger HR, suggesting that
D56-Rslh1 promotes activation despite a noncognate DOM4(A),
CTD(B) combination (Fig. 2 G and H). To test whether DOM6-R
alone enables this activity, we compared WRKY substitutions by
LexA in RRS1-R and RRS1-S, and also RRS1(AAAABA) and
RRS1(AAAABB) for their activities with RPS4(AAAB). Although
all RRS1 chimeras coexpressed with RPS4 are autoactive, only
RRS1-R(AAAALA) and RRS1-R(AAAABA) with a DOM6-R
trigger HR with RPS4(AAAB) (Fig. 2 G and H). In contrast,
RRS1-S(AAAALA) with DOM6-S and RRS1-R(AAAABB) with
DOM6-B exhibit no or weak HR in the presence of RPS4(AAAB),
suggesting that DOM6-R is specifically required to function with
RPS4(AAAB) (Fig. 2 G and H). Since DOM6-R is able to com-
pensate for a DOM4–CTD mismatch, it may promote activation
via assisting or modulating DOM4–CTD association.
In summary, we identified distinct genetic requirements in
RPS4 and RRS1 for PopP2 and AvrRps4 responsiveness. DOM6-R
enables PopP2-triggered activation of the complex, possibly by
modulating interactions between DOM4 and CTD or DOM4 and
WRKY domain.
Interactions Between DOM4 and D56 of RRS1 Are Influenced by
Effectors, Mutations, and Domain Swaps That Activate the Complex.
We hypothesized that the WRKY domain (DOM5) negatively
regulates the RRS1–RPS4 complex preactivation, and that dur-
ing effector-imposed alleviation of that negative regulation,
DOM4 plays a role in activating the complex. We found that for
RRS1-R domains, DOM4(A) coimmunoprecipitates with D56-R
(AA), and DOM4(A) coimmunoprecipitates more strongly with
DOM5(A) than with DOM6-R(A) (Fig. 3A). This suggests that,
in RRS1-R, DOM4–D56-R association is mainly via the WRKY
domain and that the DOM4–WRKY interaction likely inhibits
the complex. In contrast, D56(BB) of RRS1B fails to coimmu-
noprecipitate with DOM4(A) of RRS1, and DOM5(B) coim-
munoprecipitates less than DOM5(A) with DOM4(A) (Fig. 3A).
The autoactivity of RRS1-R(AAAABB) and RRS1-R(AAAABA)
might arise because D56(BB) or DOM5(B) fails to impose a
strong negative regulation on DOM4(A), derepressing RRS1, as
does deletion of D56-R in RRS1-RΔD56.
We next tested whether the autoactivity of several RRS1-R
WRKY domain mutants correlates with lack of D56–DOM4
interactions. We assessed interactions of RRS1-R DOM4 with
D56-R carrying autoactive mutations slh1 or K1221Q (K2Q), or a
nonautoactive mutation K1221R (K2R), and found that all D56-
R mutants coimmunoprecipitate with DOM4 (Fig. 3B). Com-
pared with D56-R and D56-RK2R (lanes 1 and 3), DOM4
coimmunoprecipitates less with D56-Rslh1 and D56-RK2Q (lanes
2 and 4) (Fig. 3B). However, as these autoactive D56-R forms
show lower levels in the input, it is difficult to quantitatively
compare their strength of interactions. In addition, D56-S from
RRS1-S, with an identical DOM5 to RRS1-R and a shorter
DOM6-S, also show lower levels in the input and coimmuno-
precipitates less with DOM4 (lane 5) than D56-R (Fig. 3B).
These data suggest that RRS1 autoactive forms can promote
defense without abolition of DOM4/D56 affinity. Conceivably,
certain mutations in the WRKY domain can cause a change in the
DOM4/D56 conformation that is not reflected by affinity differ-
ences in co-IP assays, but is sufficient to derepress RRS1-R. In-
terestingly, DOM4(B) coimmunoprecipitates with both D56(AA)
and DOM5(A), but with no or weaker affinity to D56(BB) and
DOM5(B) (SI Appendix, Fig. S3A), suggesting that mechanisms of
autoinhibition might differ between RRS1 and RRS1B.
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Fig. 2. Distinct genetic requirements in RPS4 and RRS1 for PopP2 and
AvrRps4 responsiveness, and for autoactivity. (A) RPS4 C-terminal domain
(CTD) is required for RPS4 + RRS1-RΔD56–triggered HR. Each leaf section was
coinfiltrated to express RRS1-RΔD56 with a CTD variant of RPS4. Deletion of
CTD (ΔCTD), CTD swap with RPS4B [RPS4(AAAB)], or several mutations in
CTD (C887Y, S914F, G952E, G997E) impair the HR activity of RPS4 + RRS1-
RΔD56. (B) DOM4 swap with RRS1B and/or CTD swap with RPS4B influence
effector responsiveness of RRS1-R/RPS4. Each leaf section was coinfiltrated
to express wild-type or chimeric RRS1-R and RPS4 with mCh, AvrRps4, or
PopP2. (C–E ) Mutations S983F, E1070K in RRS1-R DOM4, and C887Y in RPS4
CTD primarily impair PopP2-, but not AvrRps4-triggered HR. Each leaf
section was coinfiltrated to express wild-type or mutant RRS1-R, RPS4 with
mCh, AvrRps4, or PopP2. (G) DOM6 of RRS1-R is required to compensate for
the noncognate RRS1 DOM4(A) and RPS4B CTD(B) combination. Each leaf
section was coinfiltrated to express either RPS4 or RPS4(AAAB) with an
autoactive RRS1 variant. Only the RRS1 variants possessing a DOM6-R
trigger HR with RPS4(AAAB). For A–E and G, HRs were assessed at 4 dpi.
Photographs are representative of three consistent replicates. (F and H)
Percentage representations of cell death scores in C–H at 4 dpi. Stacked
bars are color-coded to show the proportions (in percentage) of each cell
death scale (0–5) out of the total infiltrated panels scored. Panel (0) in cell
death score is reused from the second row of G. Total panels scored are 7–19
(F) and 9–11 (H).
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AvrRps4 and PopP2 are detected by the WRKY domain of
RRS1. We hypothesized that effector engagement with the
WRKY domain derepresses RRS1 by interfering with interac-
tions between DOM4 and D56. AvrRps4 inhibits DOM4–D56-R
interactions in co-IP assays (Fig. 3C). We mutated residues
(E187, E175) of AvrRps4 reported previously to be important
for recognition (35) and verified that both AvrRps4-E187A and
the E187A/E175A (hence, AvrRps4-EEAA) lose recognition by
RRS1-R/RPS4 (SI Appendix, Fig. S3B). Importantly, AvrRps4
E187A and EEAA, which exhibit weak and no affinity to D56-R,
respectively, show reduced or no interference with DOM4–D56-R
association (Fig. 3C). In contrast, although not recognized,
AvrRps4-KRVYAAAA (AvrRps4-KRVY) can interfere with
DOM4–D56-R associations, although less than AvrRps4. This is
consistent with the strong affinity observed between AvrRps4-
KRVY and D56-R (Fig. 3C). These data suggest that AvrRps4
derepresses RRS1 via disrupting DOM4–D56 associations, and
inadequate disruption by E187A and EEAA mutants explains their
inability to activate RRS1-R/RPS4. On the other hand, AvrRps4-
KRVY suppresses DOM4–D56 association, indicating that re-
ducing DOM4–D56 association is not sufficient to activate defense.
PopP2 shows a weaker interference of DOM4–D56-R associa-
tion compared with AvrRps4 (Fig. 3D). Consistently, D56-RK2Q
(K1221Q), which mimics PopP2 acetylation of the WRKY domain
residue K1221, does not show complete loss of association with
DOM4 (Fig. 3B). PopP2 also suppresses DOM4–D56-S association
(Fig. 3D), even though RRS1-S cannot activate defense in response
to PopP2. The enzymatically inactive mutant PopP2-C321A ex-
hibits moderate suppression of both DOM4–D56-R and DOM4–
D56-S associations, resembling the effect of PopP2 (Fig. 3D and SI
Appendix, Fig. S3B). Overall, PopP2 acetylation of the WRKY
domain may not lead to complete dissociation of DOM4–D56-R,
and PopP2 likely activates the complex differently than AvrRps4.
RPS4 CTD Interacts with RRS1 D456, but Changes in RPS4 CTD–D456
Affinity Do Not Explain the Difference Between Inactive and
Activated Forms of the Complex. We investigated interactions of
CTD with domains 4, 5, and 6 of RRS1 and found that RPS4
CTD associates with RRS1 DOM4 (Fig. 4A). We hypothesized
that this association might be important for signal transduction
between the sensor (RRS1) and the executor (RPS4) and tested
whether mutations or domain swaps that compromise signaling
also impair their interactions. DOM4(RRS1) coimmunoprecipi-
tates with both CTD(RPS4) and CTD(RPS4B). However, cognate
pairs [DOM4(A)–CTD(A); DOM4(B)–CTD(B)] did not show
stronger affinity than the noncognate pairs [DOM4(B)–CTD(A);
DOM4(A)–CTD(B)] (SI Appendix, Fig. S4A). Similarly, associations
between mutants of DOM4 or CTD are unaltered in co-IP (SI
Appendix, Fig. S4B).
The RPS4 CTD coimmunoprecipitates more strongly with
D456-R than with DOM4 but does not associate with D56-R
(Fig. 4 A and B), suggesting that CTD and DOM4 interactions
A
C D
B
Fig. 3. Interactions between DOM4 and D56 of RRS1 are influenced by
effectors, mutations and domain swaps that activate the complex. (A) Co-IP
assays to assess RRS1-R DOM4(A):GFP association with HF-tagged D56,
DOM5, and DOM6-R of RRS1-R (A) and RRS1B (B) after transient coex-
pression in Nb leaves. DOM4(A) coimmunoprecipitates more strongly with A
compared with B domains. (B) Co-IP assays to assess RRS1-R DOM4:GFP as-
sociation with different alleles or mutants of D56:HF. D56-R and D56-S are of
RRS1-R and RRS1-S, respectively. K2Q and K2R are acetyl-mimic and acetyl-
null mutations of K1221 in RRS1-R WRKY domain. slh1 is a leucine insertion
in RRS1-R WRKY domain. (C and D) Co-IP assays reveal effector interference
with DOM4:GFP–D56-R:HF or DOM4:GFP–D56-S:HF association. Effectors are
tagged with mCherry (mCh). Controls include AvrRps4 mutants E187A,
E187A/E175A (EEAA) and KRVYAAAA (KRVY), a PopP2 mutant C321A, and
mCherry. AvrRps4 inhibits DOM4–D56-R association, and PopP2 weakly in-
terferes with both DOM4–D56-R and DOM4–D56-S association. Immunoblots
show protein accumulations in total extracts (input) and after IP with anti-
FLAG(IP-FLAG) or anti-GFP(IP-GFP) beads. Asterisks mark bands that indicate
(lack of) associations. These were repeated three times with similar results.
A B C
Fig. 4. Interactions between RPS4 CTD and RRS1 D456 are influenced by
effectors and mutations that activate the complex. (A) Co-IP assays to assess
RPS4 CTD:HF association with GFP-tagged DOM4, D56-R, D456-R of RRS1-R
after coexpression in Nb leaves. CTD coimmunoprecipitates strongly with
D456-R and more weakly with DOM4, but not with D56-R. (B) Co-IP assays to
show RPS4 CTD:GFP association with mutants of D456-R:HF (K2Q, K2R, slh1).
CTD coimmunoprecipitates more weakly with these mutants than with
D456-R. (C) Co-IP assays reveal effector interference of RPS4 CTD:GFP and
RRS1-R D456-R:HF associations. Effectors are tagged with mCh. Controls in-
clude AvrRps4 mutant EEAA, PopP2 mutant C321A, and mCherry. AvrRps4
but not PopP2 interferes with CTD–D456-R associations. Immunoblots show
protein accumulation in input and after IP-FLAG or IP-GFP. Asterisks mark
bands that indicate association. These were repeated three times with sim-
ilar results.
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are likely modulated by D56-R. However, coexpression in trans
of D56-R with DOM4 does not alter DOM4–CTD association
affinity (lanes 2 and 5) (Fig. 4A). D56-R might enhance D456-
R’s affinity with CTD in cis, which could change upon mutation-
or effector-triggered derepression. We tested the affinity of
several D456-R mutants (K2Q, K2R, slh1) with CTD, and our
data suggest that all mutants coimmunoprecipitate more weakly
than wild type (lane 3) with CTD (Fig. 4B). We also found that
AvrRps4, but not EEAA, slightly reduces D456-R–CTD associ-
ation by co-IP in both directions (Fig. 4C and SI Appendix, Fig.
S4C), suggesting that a derepressed D456-R has reduced affinity
with RPS4 CTD. However, PopP2 or PopP2-C321A do not
suppress D456-R–CTD association (Fig. 4C). As PopP2 shows a
weaker interference of DOM4–D56-R association compared
with AvrRps4 (Fig. 3 C and D), it is likely that PopP2 derepresses
D456-R differently, which alters D456-R’s association with RPS4
CTD to activate defense without reducing their affinity.
In summary, RPS4 CTD associates with RRS1 D456, likely via
interactions with DOM4 that are potentiated by DOM56.
However, the mechanism of RPS4 activation by activated RRS1
cannot be explained by changes in the presence or absence of
CTD–DOM4 interactions.
Bimolecular Fluorescence Complementation Analyses Reveal Effector-
Dependent Conformational Differences in RRS1 D456. Genetic and
biochemical data above highlight the importance of RRS1 D456
during autoinhibition and activation of the immune complex. We
investigated preactivation and postactivation conformational
differences of D456 using bimolecular fluorescence comple-
mentation (BiFC). We visualized DOM4–D56-R associations
using cCFP:D456-R:nVenus (Fig. 5E and SI Appendix, Fig. S5H)
or cCFP:D456-R:nCerulean (nCer) (SI Appendix, Fig. S5D),
which show strong BiFC signals (YFP and CFP, respectively) in
nuclei after transient expression in Nb leaves, as does cCFP:
D456-S:nVenus (Fig. 5E). Assuming that intramolecular inter-
actions within D456 give rise to these BiFC signals, these results
suggest a “closed” D456 conformation preactivation, with N and
C termini of RRS1 D456 in close proximity. As D456-R self-
associates in co-IP assays (SI Appendix, Fig. S5 A and B), it is
also possible that these signals are produced intermolecularly,
meaning that N terminus (DOM4) of one molecule could asso-
ciate with C terminus (DOM6) of another. In one such scenario,
two linear D456 molecules associate in an antiparallel manner
(“open” model), and the N and C termini of D456 would not be
in close proximity, contrary to the anticipated closed model (SI
Appendix, Fig. S5C). To distinguish these scenarios, we tested the
combinations cCFP:D456-R + nCer:D456-R (N + N), D456-R:
cCFP + D456-R:nCer (C + C), and cCFP:D456-R + D456-R:
nCer (N + C). All combinations (N + N, C + C, N + C) produce
significantly weaker BiFC signals compared with cCFP:D456-R:
nCer, favoring the closed model (SI Appendix, Fig. S5 D and E).
Furthermore, the higher signal intensities shown for cCFP:D456-
R:nCer (SI Appendix, Fig. S5 D and E), strongly suggest that
intramolecular rather than intermolecular interactions contrib-
ute to its BiFC signal. These data suggest that, in the absence of
effector, the N and C termini of D456 are in close proximity.
We set out to assess changes in D456 in the context of full-
length RRS1, as D456-R cannot activate RPS4 upon effector
treatment (SI Appendix, Fig. S5F). We generated RRS1-R
(cCFP-nVenus), carrying a cCFP between LRR and DOM4 and
an nVenus at the C-terminal end. Importantly, RRS1-R(cCFP-
nVenus) can respond to AvrRps4, but not to PopP2, when
coexpressed with RPS4, albeit more weakly than RRS1-R:HF
(6×His3×FLAG) (Fig. 5A). RRS1-R(cCFP-nVenus) exhibits
A
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Fig. 5. BiFC analyses reveal effector-dependent conformational differences in RRS1 D456. (A) RRS1-R(cCFP-nVenus) + RPS4 respond to AvrRps4 (weaker than
RRS1-R:HF + RPS4), but not PopP2, in tobacco transient assays. Diagram of RRS1-R(cCFP-nVenus) illustrates a cCFP between LRR and DOM4, and an nVenus at
the C terminus. HRs were assessed at 3 dpi. Photographs are representative of three consistent replicates. (B–D) Nuclear BiFC signal of RRS1-R(cCFP-nVenus) is
reduced in the presence of AvrRps4:mCh, but not AvrRps4 mutants, after coexpression in Nb leaves at 2 dpi. Representative images are shown (B). Box plots
show quantifications of YFP signals (C) and mCh signals (D). (E–G) Nuclear BiFC signals of cCFP:D456-R:nVenus or cCFP:D456-S:nVenus remain unaltered in the
presence of PopP2:mCh or C321A:mCh, compared with mCherry control. Representative images are shown (E). Box plots show quantifications of YFP signals
(F) and mCh signals (G). Signal intensity of YFP (B and F) or mCh (C and G) was quantified as average gray value of each nucleus, and then each normalized to
the mean intensity (YFP or mCh) of the mCh control sample within each biological replicate. Data points, color-coded for different biological replicates,
represent Log10 of the normalized values. Linear mixed-effects model (lme) and tests for general linear hypotheses (glht) with Tukey comparisons were used
for statistical analysis. Means with the same letter are not significantly different (P < 0.001).
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strong BiFC signals in the absence of effectors (Fig. 5B).
Conceivably, the affinity of cCFP for nVenus partially compro-
mises functionality of the RRS1–RPS4 complex. This suggests
that preactivation, the N terminus of DOM4 is close to the C
terminus of DOM6-R in full-length RRS1-R, forming a closed
D456-R. AvrRps4 interferes with the BiFC signal of RRS1-R
(cCFP-nVenus), whereas neither mutant (EEAA nor KRVY)
significantly alters this BiFC signal compared with the mCherry
(mCh) control (Fig. 5 B and C) despite comparable expression
levels (Fig. 5D). We quantified BiFC signal intensity in each
nucleus, and then normalized to the average value of RRS1-R
(cCFP-nVenus) +mCh to compare different effector treatments,
enabling evaluation of statistical significance in BiFC differences
(Fig. 5C and SI Appendix, Table S2). Similarly, quantification of
mCherry signals was used to compare effector expression levels
(Fig. 5D). These data suggest that AvrRps4 separates RRS1
DOM4 from D56 during activation of the immune complex. The
RRS1 fusion protein accumulation is unaltered when coex-
pressed with AvrRps4 or effector mutants compared with the
mCherry control (SI Appendix, Fig. S5G), indicating the reduced
BiFC signal is not caused by destabilization of RRS1.
We also tested the effect of AvrRps4 on cCFP:D456-R:nVenus
BiFC signal. Compared with cCFP:D456-R:nVenus coexpressed
with mCherry, coexpression with AvrRps4 but not EEAA signif-
icantly reduces the cCFP:D456-R:nVenus BiFC signal in nuclei
(SI Appendix, Fig. S5 H and I). Coexpression of KRVY also
suppresses the BiFC signal of cCFP:D456-R:nVenus, although to
a lesser extent compared with AvrRps4 (SI Appendix, Fig. S5 H
and I). We confirmed that the overall expression level of AvrRps4
is indistinguishable from EEAA or KRVY (SI Appendix, Fig. S5J).
These observations are consistent with the co-IP data (Fig. 3C),
together suggesting that AvrRps4 disrupts DOM4–D56-R associ-
ation via its interactions with DOM5, thus interfering with the
closed conformation of D456-R.
Since the full-length RRS1-R(cCFP-nVenus) is nonresponsive
to PopP2, we investigated the effect of PopP2 on D456-R. Nei-
ther PopP2 nor C321A interferes with the BiFC signal of cCFP:
D456-R:nVenus (Fig. 5E). We also tested the effect of PopP2 on
D456-S and observed no significant changes of cCFP:D456-S:
nVenus BiFC signal in the presence of PopP2 or C321A (Fig. 5 E
and F). The expression levels of PopP2 and C321A are not dif-
ferent (Fig. 5G).
Overall, we can thus distinguish domain configurations of
RRS1 D456 before and after activation. Co-IP results show a
negative correlation between DOM4–WRKY association affinity
and immune complex activity. BiFC data reveal a decrease in
proximity of D456 N and C termini upon activation. We there-
fore infer a change from closed to open conformation of D456
domains during activation. AvrRps4 shows stronger interference
with D456 conformation in co-IP than PopP2, and PopP2 shows
no interference in BiFC, supporting the idea that AvrRps4 acts
differently to PopP2 to activate the immune complex.
FRET Analyses Reveal Differences in RRS1 D456 Conformation Preactivation
and Postactivation.To complement the BiFC method and to monitor
dynamic changes of D456 upon activation, we established an in vivo
FRET system. In FRET, the energy transfer from donor fluo-
rophores (eCFP) to nearby acceptor fluorophores (YFP) occurs
through a dynamic and reversible dipole-to-dipole coupling, and
can be quantified using acceptor photobleaching (FRET-AB).
This provides a powerful tool to detect small changes in proximity.
We anticipate the FRET efficiencies of eCFP:D456-R:YFP would
reflect a range of open (lower FRET) or closed (higher FRET)
states of D456-R (Fig. 6A). To eliminate the variability of
cotransformation efficiency, we built constructs carrying eCFP:
D456-R:YFP with AvrRps4:mCherry, or with controls 35S:mCherry,
EEAA:mCh and KRVY:mCh, on the same T-DNA (Fig. 6B). We
observed high FRET efficiencies of eCFP:D456-R:YFP (average,
∼31%) with mCh, and AvrRps4 significantly lowers this FRET
efficiency (average ∼25.4%), indicating reduced proximity be-
tween N and C termini of D456 and therefore a more open
conformation (Fig. 6C). In contrast to AvrRps4, the presence of
EEAA does not significantly reduce the FRET efficiency com-
pared with mCh (Fig. 6C). KRVY decreases the FRET efficiency
to a level intermediate between AvrRps4 and EEAA, but not
significantly different from either (Fig. 6C). We compiled FRET
efficiency of single-cell measurements from different biological
replicates, and compared the means to establish statistical sig-
nificance (Fig. 6C and SI Appendix, Table S2).
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Fig. 6. FRET analyses reveal differences in RRS1 D456 conformation preactivation and postactivation. (A) Cartoon illustrates how FRET reflects possible
conformational differences of eCFP:D456-R:YFP. (B) Diagrams illustrate plasmid design for FRET assays. LB and RB indicate T-DNA left and right borders,
respectively. For simplicity, details of the promoters and terminators are omitted from the cartoon and are in SI Appendix. (C) FRET efficiency of eCFP:D456:
YFP is significantly reduced in the presence of AvrRps4 and AvrRps4(KRVY), but not AvrRps4(EEAA), compared with mCherry(mCh) control. FRET analyses
were performed after transient expression of described constructs (B) in Nb leaves at 2 dpi. Data points, pooling several biological replicates, each represents a
single-cell FRET efficiency (in percentage) quantified by FRET-AB. Linear mixed-effects model (lme) and tests for general linear hypotheses (glht) with Tukey
comparisons were used for statistical analysis. Means with the same letter are not significantly different (P < 0.001).
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We also tested whether the autoactive domain swaps D456
(ABA) and D456(ABB) affect the conformation of D456-R. In
BiFC assays, both cCFP:D456(ABA):nCer and cCFP:D456
(ABB):nCer produce significantly lower signals than cCFP:
D456-R(AAA):nCer (SI Appendix, Fig. S6 A and B). We con-
firmed in FRET assays that eCFP:D456(ABA):YFP and eCFP:
D456(ABB):YFP show significantly lower FRET efficiencies
than eCFP:D456-R(AAA):YFP (SI Appendix, Fig. S6C). These
data indicate the chimeric domains D456(ABA) and D456
(ABB) show reduced proximity of their N and C termini com-
pared with D456-R(AAA), possibly due to lower affinity be-
tween DOM4(A) and D56(BB) or D56(BA). Notably, cCFP:
D456(BBB):nCer produces no BiFC signal (SI Appendix, Fig. S6
A and B), consistent with the lack of DOM4(B) and D56(BB)
interactions in co-IP (SI Appendix, Fig. S3A), suggesting that
D456(BBB) of RRS1B has a different conformation compared
with RRS1.
Overall, co-IP, BiFC, and FRET experiments demonstrate
that AvrRps4 but not PopP2 can disrupt WRKY association with
DOM4 of RRS1. We suggest this disruption makes a key con-
tribution to RRS1-R–RPS4 complex activation by AvrRps4, but
that activation via PopP2 acetylation of the WRKY domain is via
more subtle conformational changes that require the participa-
tion of the longer domain 6 in RRS1-R.
Engineered RRS1-R with a Reversibly Closed D456-R Shows Reversible
Loss of Defense Activation. To test further whether conformational
changes of RRS1 D456-R are essential for defense activation, we
engineered a reversible “molecular lock” around RRS1-R D456-
R. The “lock” comprises Escherichia coli colicin and immunity
proteins that interact with high affinity (dissociation constant,
∼10−16 M). We used an enzymatically inactive form of the colicin
E9 endonuclease (E9), and its cognate inhibitor immunity pro-
tein, Im9 (36). Inserting Im9 and E9 within a full-length RRS1-R
at the N and C termini of D456-R, forming RRS1-R(Im9-E9),
locks D456-R in closed conformation (Fig. 7A). To achieve re-
versibility, we included a tobacco etch virus (TEV) cleavage
site between DOM6 and the N terminus of E9, which allows
“unlocking” in the presence of TEV protease (Fig. 7A).
We first confirmed that insertion of Im9 between the LRR
domain and D456-R, forming RRS1-R(Im9), or fusion of E9 at
the C terminus, forming RRS1-R (E9), does not compromise
autoinhibition or AvrRps4 responsiveness of RRS1-R (Fig. 7B).
Intriguingly, only when the N and C termini of D456-R are simul-
taneously tagged with Im9 and E9 [RRS1-R(Im9-E9)], AvrRps4
responsiveness is lost. This was largely restored by coexpressing TEV
protease, suggesting that cleavage-dependent relief of the “locked”
D456-R allows conformational changes in D456-R that are neces-
sary for AvrRps4-triggered activation (Fig. 7B). As an additional
control, we introduced mutations at the E9/Im9 interface, Y54A,
Y55A (Im9YYAA), and F86A (E9F86A), to abrogate their interaction
(36). We found that RRS1-R(Im9YYAA-E9F86A) together with RPS4
responds like RRS1-R to AvrRps4, suggesting that tagging with
“nonsticky” E9 and Im9 does not interfere with AvrRps4-triggered
conformational changes in RRS1-R (Fig. 7 A and B). We confirmed
accumulations of these engineered RRS1-R proteins, before and
after TEV cleavage (SI Appendix, Fig. S7A).
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Fig. 7. Engineered RRS1-R with a reversibly closed D456-R shows reversible
loss of defense activation. (A) Schematic overview of RRS1-R engineering.
Tagging the N and C termini of D456-R within a full-length RRS1-R with
high-affinity proteins Im9 and E9 imposes a closed D456-R conformation. A
TEV cleavage site at the N terminus of E9 is designed to allow cleavage and
thus relieves this closed conformation upon coexpression of TEV protease.
Interface mutants Im9YYAA and E9F86A that abolish Im9–E9 interactions were
used to engineer a control open RRS1-R. (B) Engineered RRS1-R with a re-
versibly closed D456-R shows reversible loss of defense activation by AvrRps4.
Each tobacco leaf section was coinfiltrated to transiently express RPS4 and an
engineered RRS1-R with mCherry (mCh) or AvrRps4. RRS1-R(Im9) carries
an Im9 between LRR and DOM4. RRS1-R(E9) contains an E9 fused to the
C terminus. RRS1-R(Im9-E9) and RRS1-R(Im9YYAA-E9F86A) are simultaneously
tagged with Im9 and E9 or their mutants, respectively. (C and D) Engineered
RRS1-Rslh1 or RRS1-RK2Q with a reversibly closed D456-R shows reversible loss
of autoactivity. Each leaf section was coinfiltrated to express RPS4 with an
engineered RRS1-Rslh1 or RRS1-RK2Q. HRs were assessed at 4 dpi. Photographs
are representative of three consistent replicates.
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To distinguish whether the loss of AvrRps4 responsiveness by
RRS1-R(Im9-E9) results from Im9–E9 interaction within one
molecule (intramolecular) or between two molecules (intermo-
lecular), we coinfiltrated RRS1-R(Im9) and RRS1-R(E9) with
RPS4 (SI Appendix, Fig. S7B). AvrRps4 responses are uncom-
promised, suggesting that Im9 and E9 interactions between two
different RRS1-R molecules do not compromise defense acti-
vation (SI Appendix, Fig. S7C). This is consistent with our data
showing that the closed confirmation of D456-R is maintained
via domain interactions within, rather than between, RRS1-R
molecules (SI Appendix, Fig. S5 C–E).
In contrast, PopP2 responsiveness is impaired but not abolished
by C-terminal tagging with E9 in RRS1-R(E9) (SI Appendix, Fig.
S7 D and E), again indicating an important requirement for
DOM6-R in PopP2 but not AvrRps4 responsiveness. Compared
with RRS1-R, RRS1-R(Im9) + RPS4 has a weaker response to
PopP2, although not as weak as RRS1-R(E9). RRS1-R(Im9-E9) +
TEV and RRS1-R(Im9YYAA-E9F86A) together with RPS4 also
lack PopP2 responses (SI Appendix, Fig. S7 D and E). This suggests
that PopP2 responsiveness is more sensitive to structural alter-
ations of RRS1-R compared with AvrRps4, consistent with the
lack of PopP2 responses by RRS1-R(cCFP-nVenus) (Fig. 5A).
We similarly engineered E9 and Im9 into the autoactive alleles
RRS1-Rslh1 and RRS1-RK2Q. When either N or C terminus of
D456-R of RRS1-Rslh1 was tagged with E9 or Im9, respectively,
its autoimmune phenotype was unaltered (Fig. 7C). In contrast,
the RPS4-dependent autoactivity was completely lost in RRS1-
Rslh1(Im9-E9) or RRS1-RK2Q(Im9-E9) (Fig. 7 C and D), sug-
gesting that “locked closed” D456 can prevent constitutive de-
fense activation triggered by mutations in the WRKY domain
(slh1, K2Q). Furthermore, “unlocking D456-R” by coexpressing
TEV partially restores their autoactivity (Fig. 7 C and D).
Conceivably, the detached E9 after TEV cleavage interacts with
the Im9 embedded in RRS1-R, which might reduce complex
activation, causing a weaker HR.
Validation of functional relevance of conformational changes is
a nontrivial challenge. By engineering RRS1-R with a cleavable
molecular lock, we were able to reversibly close D456-R, dem-
onstrating that conformational changes of D456 are essential for
AvrRps4-triggered activation. This Im9/E9 reversible protein en-
gineering tool opens avenues for investigating conformational
change of immune receptors during activation and is broadly ap-
plicable to many other protein complexes.
Discussion
How paired NLRs convert effector recognition into defense
activation is poorly understood. We hypothesize that, upon ef-
fector perception, the sensor NLR activates a chain of domain
reconfigurations that derepress the executor NLR, eventually
allowing its signaling domain to activate defense. In the absence
of structural knowledge, obtaining insights into conformational
changes of multidomain protein complexes is challenging.
We addressed this challenge in the RPS4–RRS1 system. Using
deletions and domain swaps, we found that the sensor WRKY
domain negatively regulates the RPS4–RRS1 complex. Bio-
chemical and cell biology data support a model in which
AvrRps4 derepresses RRS1 via disrupting DOM4–WRKY as-
sociation, enabling D456 to activate via the RPS4 CTD. PopP2-
triggered activation is less easily explained by such disruptions
and likely involves the longer DOM6 of RRS1-R. We propose
that PopP2 acetylation of the WRKY domain derepresses
DOM6 of RRS1-R, allowing it to alter D456–CTD interactions
via mechanisms that are different from AvrRps4. These obser-
vations show that a crucial contribution to RPS4–RRS1 activa-
tion is derepression of RRS1 D456.
To investigate dynamic changes of NLR domains upon ef-
fector treatment, we used FRET, which is more sensitive and
quantitative in spatial comparisons. We observed a gradient of
FRET efficiency with or without AvrRps4. Conceivably, D456
fluctuates between closed and open conformations, and effector
engagement promotes accumulation of the active form, eventu-
ally activating RPS4. This fits with the equilibrium model de-
scribed for L6 (10), which could also apply to multipartner NLR
complexes, highlighting a threshold for activation determined by
gradual conformational changes. The end point for defense ac-
tivation is likely to be oligomerization of the RPS4 TIR domain,
but other components of the complex may also contribute. Im-
portantly, although expression of RPS4 alone can activate HR
(37), a much stronger HR is seen upon activation of the RPS4–
RRS1-R complex by an effector, and thus immune complex
activation is not a simple derepression of an executor but also
involves activation of RPS4 by RRS1.
Domain swap analysis suggests that DOM4 of RRS1-R and
CTD of RPS4 coevolved to mediate signal transduction between
the sensor and executor. Although DOM4(A) coimmunopreci-
pitates with CTD(B), and DOM4(B) with CTD(A), DOM4 or
CTD swaps between A and B pair proteins can result in immune
complexes unable to respond to effectors. Intriguingly, homol-
ogous sequences of DOM4 and CTD are found in other paired
TNLs that are arranged in a head-to-head orientation, such as
CHS3/CSA1, CHS1/SOC3, At4g12010/At4g12020, At4g19530/
At4g19520, At3g51570/At3g51560, and At4g36150/At4g36140 (31,
38, 39), implying a conserved coupling of DOM4-like and CTD-
like domains in paired TNLs. We speculate that DOM4 and
CTD might enable the sensor to activate the executor in other
TNL pairs.
Interestingly, RRS1-like genes lacking a WRKY domain are
found in Arabidopsis lyrata and Brassica rapa (26), perhaps re-
sembling an ancestral Arabidopsis thaliana (At) RRS1 before the
WRKY integration event. Each are adjacent to an RPS4-like
gene, but these WRKY-lacking RRS1-like genes do not cause
autoactivation of defense. Thus, we speculate that the WRKY
domain initially fused to an ancestral AtRRS1 was not required
for autoinhibition, and its pivotal role in negatively regulating the
immune complex likely evolved gradually. The integrated
WRKY domains evolve toward the optimal balance at which
they are sensitive enough to activate a signaling response rapidly
upon effector detection, while limiting inappropriate activation
in the absence of a pathogen. Consistent with this idea, we found
that appropriate interactions between WRKY and DOM4 of
RRS1 are required for autoinhibition, and an independently
evolved RRS1B WRKY domain is incompatible for such inter-
actions when swapped into RRS1, resulting in autoactivity.
IDs play a crucial role in NLR activation. They can act both as
the effector sensor and as a central regulator, allowing rapid yet
specific activation in response to pathogen perception. Consis-
tent with this, a mutation in an ID of CHS3 also results in au-
toimmunity, which is dependent on the linked RPS4-like CSA1
(38), suggesting that this ID also negatively regulates this paired
TNL. The discovery of NLR-IDs raised the exciting possibility of
engineering synthetic resistance genes in which the ID in an
NLR is replaced with another ID that is also a pathogen target.
However, our data suggest that it will not be easy to engineer
new IDs into RRS1-R without creating RPS4-dependent con-
stitutively active alleles. Better understanding of how IDs regu-
late immune receptors would help to uncouple the regulatory
requirements from their effector detection capacities and better
inform resistance engineering.
Materials and Methods
The materials and methods used in this study are described in detail in SI
Appendix, SI Materials and Methods, including plant materials, cloning details
for plasmid construction, and protein engineering. It also includes detailed
information regarding tobacco transient assays, immunoblot analysis, co-IP
assays, BiFC assays, and FRET assays, and quantification and statistical analysis.
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